NCT06220461View on ClinicalTrials.gov

Folic Acid Supplementation to Reduce Anemia in Extremely Preterm Infants

NANot yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2028

Conditions
Extreme PrematurityAnemia of Prematurity
Interventions
DIETARY_SUPPLEMENT

Folic acid

Infants allocated to the intervention group will receive folic acid (50 mcg flat dose/day) starting at 14 days of age.

Trial Locations (1)

T2N2T9

Foothills Medical Centre, Calgary

All Listed Sponsors
lead

University of Calgary

OTHER

NCT06220461 - Folic Acid Supplementation to Reduce Anemia in Extremely Preterm Infants | Biotech Hunter | Biotech Hunter